PARTNER PRACTICES

Cardiovascular Institute of
the South (CIS)

Cardiovascular Institute of the South (CIS) began as a one- physician practice in 1983, focused on combatting the high cardiovascular disease mortality rate in Houma, Louisiana. CIS has since grown to become a world-renowned practice with a stellar reputation for providing advanced cardiovascular care across the Southeastern US and contributing to the advancement of non-surgical and minimally-invasive cardiac treatment.

With a history of developing and applying new techniques for treating coronary and peripheral artery disease, CIS remains at the forefront of cardiovascular medicine. The practice operates 24/7 virtual care centers, office-based cath labs, and an ambulatory surgery center (ASC), offers an innovative Cardio@Home program that helps patients make lifestyle behavior modifications to improve their heart health and quality of life, and provides a wide range of services to address vein, valve/structural, peripheral artery, and cardiovascular disease. CIS physicians also lead the way in interventional cardiovascular research, serving as clinical investigators and participating in dozens of clinical trials at any given time.

Learn More About CIS

Why CIS Joined CVL

Our mission and patient-centric focus set the stage for CIS to become the inaugural practice in the CVL platform.

“The CVL model brings together very seasoned practices that have historically established themselves as market leaders, participating at the forefront of driving innovation in cardiology on a national level. We appreciated the opportunity to work alongside like-minded physicians who share the same vision of changing the way we deliver cardiovascular care across the country.”

-Ryan Hebert, MHA, RT(R), CCIR, Chief Executive Officer

What Sets CIS Apart

Here are just a few of the innovation “firsts” that continue to define the work of this premier cardiovascular practice:

1st in the Gulf South to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System. Dr. Pradeep Nair used this first-of-its-kind dissolvable stent to treat chronic limb-threatening ischemia in the lower legs in a procedure performed in May 2024.
1st in the country to use the new Aperta NSE™ PTA Balloon to treat vascular disease in the legs. Dr. Matthew Finn performed the procedure in May 2024 at a CIS ASC using this cutting-edge device.
1st in Louisiana to treat a patient using the new FDA approved Evolut™ FX+transcatheter aortic valve replacement (TAVR) system, a minimally-invasive alternative to open-heart surgical aortic valve replacement. Dr. Peter Fail, Dr. Shane Prejean, and Dr. Deborah McCollum performed the procedure in June 2024.